[144] STERIS plc SEC Filing

Rhea-AI Filing Summary

Form 144 notice for STERIS plc (STE) shows a proposed sale of 3,781 ordinary shares executed through Charles Schwab with an aggregate market value of $914,084 and listing the shares outstanding as 98,490,606. The table indicates the shares were acquired and disposed on 08/12/2025 through an employee stock option exercise with the payment described as a broker payment for a cashless exercise. The filing also discloses a prior sale during the past three months: 4,110 shares sold on 08/11/2025 for $993,562. The notice includes the broker name and exchange (Charles Schwab & Co.; NYSE) and the mandatory representation that the seller is not aware of undisclosed material adverse information.

Insights

Securities Analyst

TL;DR: Small, routine disclosure showing a cashless option exercise and immediate sale; not material to equity base.

The filing documents a proposed sale of 3,781 ordinary shares with an aggregate value of $914,084 against 98,490,606 shares outstanding, representing a de minimis fraction of total shares outstanding. The shares were both acquired and disposed on 08/12/2025 via an employee stock option exercise with settlement described as a broker payment for a cashless exercise executed through Charles Schwab on the NYSE. A recent sale on 08/11/2025 of 4,110 shares for $993,562 is also reported. Given the sizes reported, these transactions are informational but unlikely to be material to valuation.

Corporate Governance Expert

TL;DR: Disclosure complies with Rule 144 reporting for sales following a cashless exercise; includes standard seller attestation.

The document provides the required investor notice for the proposed sale and notes the seller's attestation that no undisclosed material adverse information is known. It specifies acquisition by employee stock option exercise and describes the cashless broker payment mechanism. The filing lists broker details and past three months' sales, enabling transparency about insider-originated or affiliate sales. The information presented is procedural and aligns with routine insider/affiliate reporting obligations.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	3781	914084.00	98490606	08/12/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary	08/12/2025	Employee Stock Option Exercise	STERIS plc			3781	08/12/2025	Broker Payment for Cashless Exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
JACQUELINE B KOSECOFF 70 SIR JOHN ROGERSON'S QUAY DUBLIN L2 2	STERIS plc	08/11/2025	4110	993562.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the STERIS (STE) Form 144 report?

The Form 144 reports a proposed sale of 3,781 ordinary shares of STERIS, with an aggregate market value of $914,084, to be sold on 08/12/2025 via Charles Schwab on the NYSE.

How were the 3,781 STERIS shares acquired?

The shares were acquired on 08/12/2025 through an employee stock option exercise, with payment described as a broker payment for a cashless exercise.

Did the filer report any sales in the past three months for STE?

Yes. The filing discloses a prior sale of 4,110 shares on 08/11/2025 that generated $993,562 in gross proceeds.

Which broker handled the proposed sale in the Form 144?

The broker listed for the proposed sale is Charles Schwab & Co., Inc. (address shown as 3000 Schwab Way, Westlake, TX) and the sale is listed on the NYSE.

Does the Form 144 include any representation about undisclosed information?

Yes. The notice includes the seller's representation that they do not know of any material adverse information about the issuer that has not been publicly disclosed.